2019, Number 1
<< Back Next >>
Rev Latin Infect Pediatr 2019; 32 (1)
Influenza: Is it better to get immunized with the disease than with the vaccine?
Mascareñas-de los Santos AH, Vaquera-Aparicio DN, De la O-Cavazos ME, Castillo-Bejarano JI
Language: Spanish
References: 14
Page: 7-10
PDF size: 174.58 Kb.
ABSTRACT
Influenza is an important cause of morbidity and mortality in the population. Vaccination coverage plays an important role in the reduction of complications due to the disease, besides being a cost-effective tool; however, the prevalence of myths around it leads to a decreased national coverage. In the present work, we analyze the relationship between the prevalence of complications due to the disease versus the reports of adverse effects associated with vaccination.
REFERENCES
Paules C, Subbarao K. Influenza. Lancet. 2017; 6736 (17): 1-12. doi:10.1016/S0140-6736(17)30129-0.
Haugh M, Gresset-Bourgeois V, Macabeo B, Woods A, Samson SI. A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries, Expert Review of Vaccines. 2017;
Organización Panamericana de la Salud. Actualización regional: influenza y otros virus respiratorios. 2019.
Blanton L et al. Update: influenza activity-United States, September 30, 2018-February 2, 2019. Morbidity and Mortality Weekly Report. 2019; 68 (6): 125-134.
Dirección General de Epidemiología. Informe Semanal de la Temporada de Influenza Estacional 2018-2019.
Estabragh ZR, Mamas MA. The cardiovascular manifestations of influenza: a systematic review. 2013; 167: 2397-2403.
Mizuguchi M. Influenza encephalopathy and related neuropsychiatric syndromes. Influenza other respir viruses. 2013; 7 (Suppl 3): 67-71.
Rao S, Martin J, Ahearn MA, Osborne C, Moss A, Dempsey A et al. Neurologic manifestations of influenza A(H3N2) infection in children during the 2016-2017 season. J Pediatric Infect Dis Soc. 2018.
Yoon JW et al. Analysis of clinical manifestations and laboratory findings in children with influenza B-associated myositis: a single center study. Korean Journal of family medicine. 2018; 39: 37-41.
Kelso JM. Influenza vaccine and egg allergy: nearing the end of an evidence-based journey. J Allergy Clin Immunol Pract 2015; 3: 140-141.
Evans D, Cauchemez S, Hayden FG. “Prepandemic” immunization for novel influenza viruses, “swine flu” vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events. J Infect Dis. 2000; 200 (3): 321-328.
Martín AL, Sanz R, Sáinz M, Treceño C, Carvajal A. Guillain- Barré syndrome and influenza vaccines: a meta-analysis. Vaccine. 2015; 33 (31): 3773-3778.
Vellozzi C, Iqbal S, Border K. Guillain-Barré syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis. 2014; 58: 1149-1155.
Nichol KL. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination. Vaccine. 2011; 29: 7554- 7558.
Full text